跳至主要内容
临床试验/CTRI/2018/03/012517
CTRI/2018/03/012517已完成2 期

ebulised Magnesium Sulphate in acute asthma in children - A randomized control trial - NMAC Trial

Dr SRADHANANDA ROUT0 个研究点目标入组 100 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Age group 1-14years
  • 2.Clinician diagnosed asthma
  • 3.Moderate to Severe Acute Asthma Attack defined as PRAM Score >_ 5

排除标准

  • 1.Patients who had life-threatening features [silent chest, cyanosis, bradycardia, arrhythmia, hypotension, coma,requiring intubation]
  • 2. Any contraindication to either nebulised or intravenous Magnesium Sulphate [hepatic or renal failure, heart block, or known hypomagnesemia]
  • 3. Medications containing Magnesium preparations in last 48 hours before recruitment.
  • 4.Patients with alternative diagnosis [ Pneumonia ,pleural effusion etc.]

研究者

发起方
Dr SRADHANANDA ROUT

相似试验

A clinical trial to study the effect of Magnesium... | 临床试验